Advertisement

Index by author

July 01, 1976; Volume 4,Issue 4

A

  1. Ahmed, A E

    1. Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies.
      A E Ahmed and M W Anders
      Drug Metabolism and Disposition July 1976, 4 (4) 357-361;

  2. Anders, M W

    1. Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies.
      A E Ahmed and M W Anders
      Drug Metabolism and Disposition July 1976, 4 (4) 357-361;

B

  1. Bartlett, M F

    1. Metabolism of tripelennamine in man.
      N K Chaudhuri, O A Servando, M J Manniello, R C Luders, D K Chao and M F Bartlett
      Drug Metabolism and Disposition July 1976, 4 (4) 372-378;

  2. Beghin, J

    1. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
      R M Thompson, J Beghin, W K Fife and N Gerber
      Drug Metabolism and Disposition July 1976, 4 (4) 349-356;

  3. Besselaar, G H

    1. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
      A G Zacchei, L L Weidner, G H Besselaar and E B Raftery
      Drug Metabolism and Disposition July 1976, 4 (4) 387-401;

  4. Bius, D L

    1. Buffer catalysis of the racemization reaction of some 5-phenylhydantoins and its relation to the in vivo metabolism of ethotoin.
      K H Dudley and D L Bius
      Drug Metabolism and Disposition July 1976, 4 (4) 340-348;

  5. Boyd, M R

    1. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU).
      M R Boyd and R A Neal
      Drug Metabolism and Disposition July 1976, 4 (4) 314-322;

  6. Bruce, R B

    1. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.
      L B Turnbull, L Teng, J Newman, R B Bruce and W R Maynard
      Drug Metabolism and Disposition July 1976, 4 (4) 379-386;

C

  1. Chao, D K

    1. Metabolism of tripelennamine in man.
      N K Chaudhuri, O A Servando, M J Manniello, R C Luders, D K Chao and M F Bartlett
      Drug Metabolism and Disposition July 1976, 4 (4) 372-378;

  2. Chaudhuri, N K

    1. Metabolism of tripelennamine in man.
      N K Chaudhuri, O A Servando, M J Manniello, R C Luders, D K Chao and M F Bartlett
      Drug Metabolism and Disposition July 1976, 4 (4) 372-378;

  3. Chen, P R

    1. Metabolism of 2,4,5,2',5'-pentachlorobiphenyl in the rat. Qualitative and quantitative aspects.
      P R Chen, J D McKinney and H B Matthews
      Drug Metabolism and Disposition July 1976, 4 (4) 362-367;

  4. Crew, M C

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

D

  1. Dean, A V

    1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.
      S J Lan, K J Kripalani, A V Dean, P Egli, L T Difazio and E C Schreiber
      Drug Metabolism and Disposition July 1976, 4 (4) 330-339;

  2. Deangelis, R L

    1. Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat.
      R M Welch, C R Hughes and R L Deangelis
      Drug Metabolism and Disposition July 1976, 4 (4) 402-406;

  3. De Carlo, F J

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

  4. Deluna, F A

    1. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
      D J Tocco, K F Hooke, F A Deluna and A E Duncan
      Drug Metabolism and Disposition July 1976, 4 (4) 323-329;

  5. Difazio, L T

    1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.
      S J Lan, K J Kripalani, A V Dean, P Egli, L T Difazio and E C Schreiber
      Drug Metabolism and Disposition July 1976, 4 (4) 330-339;

  6. Dudley, K H

    1. Buffer catalysis of the racemization reaction of some 5-phenylhydantoins and its relation to the in vivo metabolism of ethotoin.
      K H Dudley and D L Bius
      Drug Metabolism and Disposition July 1976, 4 (4) 340-348;

  7. Duncan, A E

    1. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
      D J Tocco, K F Hooke, F A Deluna and A E Duncan
      Drug Metabolism and Disposition July 1976, 4 (4) 323-329;

E

  1. Egli, P

    1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.
      S J Lan, K J Kripalani, A V Dean, P Egli, L T Difazio and E C Schreiber
      Drug Metabolism and Disposition July 1976, 4 (4) 330-339;

F

  1. Fife, W K

    1. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
      R M Thompson, J Beghin, W K Fife and N Gerber
      Drug Metabolism and Disposition July 1976, 4 (4) 349-356;

G

  1. Gandolfi, A J

    1. Lipid binding of a halothane metabolite. Relationship to lipid peroxidation in vitro.
      C L Wood, A J Gandolfi and R A Van Dyke
      Drug Metabolism and Disposition July 1976, 4 (4) 305-313;

  2. George, S

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

  3. Gerber, N

    1. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
      R M Thompson, J Beghin, W K Fife and N Gerber
      Drug Metabolism and Disposition July 1976, 4 (4) 349-356;

H

  1. Hasegawa, A T

    1. Effect of methadone dose on the biliary excretion of methadone metabolites in the rat.
      D L Roerig, A T Hasegawa and R I Wang
      Drug Metabolism and Disposition July 1976, 4 (4) 407-412;

  2. Herzig, D J

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

  3. Hooke, K F

    1. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
      D J Tocco, K F Hooke, F A Deluna and A E Duncan
      Drug Metabolism and Disposition July 1976, 4 (4) 323-329;

  4. Hughes, C R

    1. Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat.
      R M Welch, C R Hughes and R L Deangelis
      Drug Metabolism and Disposition July 1976, 4 (4) 402-406;

K

  1. Kripalani, K J

    1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.
      S J Lan, K J Kripalani, A V Dean, P Egli, L T Difazio and E C Schreiber
      Drug Metabolism and Disposition July 1976, 4 (4) 330-339;

  2. Kusner, E J

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

L

  1. Lan, S J

    1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.
      S J Lan, K J Kripalani, A V Dean, P Egli, L T Difazio and E C Schreiber
      Drug Metabolism and Disposition July 1976, 4 (4) 330-339;

  2. Luders, R C

    1. Metabolism of tripelennamine in man.
      N K Chaudhuri, O A Servando, M J Manniello, R C Luders, D K Chao and M F Bartlett
      Drug Metabolism and Disposition July 1976, 4 (4) 372-378;

M

  1. Manniello, M J

    1. Metabolism of tripelennamine in man.
      N K Chaudhuri, O A Servando, M J Manniello, R C Luders, D K Chao and M F Bartlett
      Drug Metabolism and Disposition July 1976, 4 (4) 372-378;

  2. Matthews, H B

    1. Metabolism of 2,4,5,2',5'-pentachlorobiphenyl in the rat. Qualitative and quantitative aspects.
      P R Chen, J D McKinney and H B Matthews
      Drug Metabolism and Disposition July 1976, 4 (4) 362-367;

  3. Maynard, W R

    1. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.
      L B Turnbull, L Teng, J Newman, R B Bruce and W R Maynard
      Drug Metabolism and Disposition July 1976, 4 (4) 379-386;

  4. McKinney, J D

    1. Metabolism of 2,4,5,2',5'-pentachlorobiphenyl in the rat. Qualitative and quantitative aspects.
      P R Chen, J D McKinney and H B Matthews
      Drug Metabolism and Disposition July 1976, 4 (4) 362-367;

  5. Melgar, M D

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

N

  1. Neal, R A

    1. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU).
      M R Boyd and R A Neal
      Drug Metabolism and Disposition July 1976, 4 (4) 314-322;

  2. Newman, J

    1. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.
      L B Turnbull, L Teng, J Newman, R B Bruce and W R Maynard
      Drug Metabolism and Disposition July 1976, 4 (4) 379-386;

R

  1. Raftery, E B

    1. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
      A G Zacchei, L L Weidner, G H Besselaar and E B Raftery
      Drug Metabolism and Disposition July 1976, 4 (4) 387-401;

  2. Roerig, D L

    1. Effect of methadone dose on the biliary excretion of methadone metabolites in the rat.
      D L Roerig, A T Hasegawa and R I Wang
      Drug Metabolism and Disposition July 1976, 4 (4) 407-412;

S

  1. Schreiber, E C

    1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.
      S J Lan, K J Kripalani, A V Dean, P Egli, L T Difazio and E C Schreiber
      Drug Metabolism and Disposition July 1976, 4 (4) 330-339;

  2. Schumann, P R

    1. 3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active species.
      F J De Carlo, D J Herzig, E J Kusner, P R Schumann, M D Melgar, S George and M C Crew
      Drug Metabolism and Disposition July 1976, 4 (4) 368-371;

  3. Servando, O A

    1. Metabolism of tripelennamine in man.
      N K Chaudhuri, O A Servando, M J Manniello, R C Luders, D K Chao and M F Bartlett
      Drug Metabolism and Disposition July 1976, 4 (4) 372-378;

T

  1. Teng, L

    1. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.
      L B Turnbull, L Teng, J Newman, R B Bruce and W R Maynard
      Drug Metabolism and Disposition July 1976, 4 (4) 379-386;

  2. Thompson, R M

    1. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
      R M Thompson, J Beghin, W K Fife and N Gerber
      Drug Metabolism and Disposition July 1976, 4 (4) 349-356;

  3. Tocco, D J

    1. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
      D J Tocco, K F Hooke, F A Deluna and A E Duncan
      Drug Metabolism and Disposition July 1976, 4 (4) 323-329;

  4. Turnbull, L B

    1. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man.
      L B Turnbull, L Teng, J Newman, R B Bruce and W R Maynard
      Drug Metabolism and Disposition July 1976, 4 (4) 379-386;

V

  1. Van Dyke, R A

    1. Lipid binding of a halothane metabolite. Relationship to lipid peroxidation in vitro.
      C L Wood, A J Gandolfi and R A Van Dyke
      Drug Metabolism and Disposition July 1976, 4 (4) 305-313;

W

  1. Wang, R I

    1. Effect of methadone dose on the biliary excretion of methadone metabolites in the rat.
      D L Roerig, A T Hasegawa and R I Wang
      Drug Metabolism and Disposition July 1976, 4 (4) 407-412;

  2. Weidner, L L

    1. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
      A G Zacchei, L L Weidner, G H Besselaar and E B Raftery
      Drug Metabolism and Disposition July 1976, 4 (4) 387-401;

  3. Welch, R M

    1. Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat.
      R M Welch, C R Hughes and R L Deangelis
      Drug Metabolism and Disposition July 1976, 4 (4) 402-406;

  4. Wood, C L

    1. Lipid binding of a halothane metabolite. Relationship to lipid peroxidation in vitro.
      C L Wood, A J Gandolfi and R A Van Dyke
      Drug Metabolism and Disposition July 1976, 4 (4) 305-313;

Z

  1. Zacchei, A G

    1. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
      A G Zacchei, L L Weidner, G H Besselaar and E B Raftery
      Drug Metabolism and Disposition July 1976, 4 (4) 387-401;
Back to top

In this issue

Advertisement